We’re excited to announce that TBD Pharmatech will be attending CPHI Europe 2025! 📅 When: 28 – 30 October 2025📍 Where: Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany🔗 Learn more & register: https://www.cphi.com/europe/en/home.html Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Frankfurt!
We’re excited to announce that TBD Pharmatech will be attending Nordic Life Science Days 2025! 📅 When: 13–14 October 2025📍 Where: Svenska Mässan, Mässans Gata/Korsvägen, 412 94 Göteborg, Sweden🔗 Learn more & register: https://nlsdays.com/ Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Gothenburg!
We’re excited to announce that TBD Pharmatech will be attending BayOConnect 2025! 📅 When: 1 – 2 July 2025, 09:00 – 18:00 CEST📍 Where: Design Offices München Macherei (M6), Weihenstephaner Str. 12, 81673 Munich, Germany🔗 Link: https://www.bayoconnect.org/en/bayoconnect-2025.html Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Munich!
We’re excited to announce that TBD Pharmatech will be attending Chemspec Europe 2025! Come meet our team to discuss your fine & specialty chemicals projects, explore partnership opportunities, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Cologne!
We’re excited to announce that TBD Pharmatech will be attending Swiss Biotech Day 2025! 📅 When: 5 – 6 May 2025📍 Where: Congress Center Basel, Messeplatz, Hall 1 (South entrance), 4058 Basel, Switzerland🔗 Learn more & register: https://swissbiotechday.ch/ Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Basel!
We’re excited to announce that TBD Pharmatech will be attending CDMO Live 2025! When: 7 – 8 May 2025 (7 May: 08:00 – 18:00; 8 May: 08:00 – 16:00)Where: World Trade Center, Beursplein 37, Meent 110, 3011 AA Rotterdam, Netherlands Learn more & register: https://pharmasource.global/events/cdmolive/ Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Rotterdam!
We’re excited to announce that TBD Pharmatech will be attending Pharma Contract Manufacturing 2025! 📅 When: 26 – 27 March 2025 Pharma IQ📍 Where: Mercure Hotel MOA Berlin, Stephanstraße 41, 10559 Berlin, Germany Pharma Advancement🔗 Learn more & register: https://www.pharma-iq.com/events-pharmacontractmanufacturing/agenda-mc Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Berlin!
We’re excited to announce that TBD Pharmatech will be attending European Chemistry Partnering 2025! 📅 When: 12 February 2025, 09:00 – 18:00 CET📍 Where: DECHEMA Society for Chemical Engineering and Biotechnology, Theodor-Heuss-Allee 25, 60486 Frankfurt am Main, Germany🔗 Learn more & register: https://www.european-chemistry-partnering.com/ european-chemistry-partnering.com Come meet our team to explore partnership opportunities, discuss your fine & specialty chemicals projects, and see how our end-to-end CDMO services can accelerate your API development and manufacturing. We look forward to seeing you in Frankfurt!
TBD Pharmatech’s recent addition of Preparative Flash Chromatography with an ELSD marks a significant enhancement in our “Small-molecule Novel Drug Ingredients Lab” project. This sophisticated system is capable of handling column sizes up to 1 kg and includes racks, tubes, and full machine qualification, which substantially increases our lab’s capacity to purify structurally sophisticated structures from complex mixtures, including high-potency active pharmaceutical ingredients (HPAPIs). The shift from preparative HPLC to Flash Chromatography allows for the purification of larger quantities, thus ensuring an efficient scale-up of synthesis processes. Additionally, this system extends the substrate scope to include less polar compounds, which
TBD Pharmatech’s recent procurement of 150L Jacketed glass reactor with thermostat, as part of the “Small-molecule Novel Drug Ingredients Lab” project, will add new capabilities to our organic synthesis services. This acquisition, funded by Enterprise Estonia (EAS) significantly enhances our capacity to conduct controlled, large-volume chemical reactions. The reactor is specifically designed for synthesizing complex chemical compounds, handling sensitive reaction conditions, and scaling up new product formulations. It is particularly effective for temperature-sensitive syntheses and multi-step organic processes, making it a critical asset for pioneering research and specialized chemical manufacturing. This upgrade will expand TBD Pharmatech’s portfolio of specialized services,